Merck Kgaa (MKGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MKGAF | UTHR | NBIX | ||
| Company | Merck Kgaa | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 152.8660 | 530.01 | 131.24 | ||
| High | 154.8020 | 532.25 | 132.20 | ||
| Low | 145.9710 | 496.44 | 128.93 | ||
| Latest | 150.5100 | 503.80 | 130.59 | ||
| Change | +4.7320 | -31.30 | -0.56 | ||
| % Change | +3.25% | -5.85% | -0.43% | ||
| Volume | 778 | 635,359 | 675,199 | ||
| 20-Day Average Volume | 407 | 344,958 | 1,283,913 | ||
| Previous Close | 145.7780 | 535.10 | 131.15 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 150.5229 | 480.59 | 133.33 | ||
| 20-Day Raw Stochastic | 82.64% | 59.81% | 46.62% | ||
| 20-Day Relative Strength | 53.79 | 57.92 | 45.72 | ||
| Weighted Alpha | +13.36 | +51.97 | +7.24 | ||
| Today's Opinion | 96% Buy | 88% Buy | 72% Sell | ||
| Previous Opinion | 64% Buy | 80% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.40% since 02/19/26 | +5.51% since 02/19/26 | +1.29% since 02/19/26 | ||
| Low | 145.5090 on 02/24/26 | 466.00 on 02/23/26 | 126.59 on 02/23/26 | ||
| High | 156.2850 on 02/20/26 | 537.19 on 02/25/26 | 132.25 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | +0.97% since 01/26/26 | +7.10% since 01/26/26 | -2.03% since 01/26/26 | ||
| Low | 140.3530 on 02/05/26 | 462.02 on 01/30/26 | 122.14 on 02/12/26 | ||
| High | 159.3380 on 01/27/26 | 537.19 on 02/25/26 | 142.82 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +13.49% since 11/26/25 | +3.80% since 11/26/25 | -13.06% since 11/26/25 | ||
| Low | 130.5500 on 11/28/25 | 455.63 on 01/20/26 | 122.14 on 02/12/26 | ||
| High | 159.3380 on 01/27/26 | 537.19 on 02/25/26 | 160.18 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +23.01% since 08/26/25 | +63.95% since 08/26/25 | -3.70% since 08/26/25 | ||
| Low | 122.7590 on 08/27/25 | 302.19 on 08/28/25 | 122.14 on 02/12/26 | ||
| High | 159.3380 on 01/27/26 | 537.19 on 02/25/26 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 21,873,870 | 23,039,796 | 13,162,606 | ||
| Shares Outstanding, K | 129,240 | 43,057 | 100,363 | ||
| Annual Sales | 22,720,720,000 | 2,877,400,000 | 2,860,500,000 | ||
| Annual Net Income | 3,056,420,000 | 1,195,100,000 | 478,600,000 | ||
| Last Quarter Sales | 5,763,570,000 | 799,500,000 | 805,500,000 | ||
| Last Quarter Net Income | 653,680,000 | 338,700,000 | 153,700,000 | ||
| 60-Month Beta | 0.96 | 0.85 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.51 on 08/01/24 | 7.70 on 02/25/26 | 1.88 on 02/11/26 | ||
| Latest Earnings Date | 11/14/24 | 02/25/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.55 | 17.94 | 28.41 | ||